<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> stable <z:hpo ids='HP_0001681'>angina pectoris</z:hpo> (CSAP) is the most common manifestation of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (CAD) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001681'>Angina pectoris</z:hpo> occurs when there is an imbalance between myocardial perfusion and the demands of the myocardium </plain></SENT>
<SENT sid="2" pm="."><plain>Elevated heart rate (HR) is an important pathophysiological variable that increases myocardial oxygen demand, and also limits tissue perfusion by reducing the duration of diastole during which most myocardial perfusion occurs </plain></SENT>
<SENT sid="3" pm="."><plain>Elevated resting HR represent a  significant predictor of <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality in the general population and patients with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) because it <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">aids</z:e> progression of this one through the development of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, plaque destabilization, and initiation of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Since β-blockers reduce HR, they are currently viewed as the first line therapy for CSAP and are associated with an improved prognosis after <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e>) or <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>The classical treatments for HR reduction show such negative aspects. β-blockers therapy exert negative effects on regional myocardial blood flow and function when HR reduction is eliminated by atrial pacing </plain></SENT>
<SENT sid="6" pm="."><plain>Calcium channel <z:chebi fb="68" ids="48706">antagonists</z:chebi> functionally antagonize coronary vasoconstriction mediated through α-adrenoreceptors and are thus devoid of this undesired effect, but the compounds are nevertheless negative inotrope </plain></SENT>
<SENT sid="7" pm="."><plain>Ivabradine (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IVA</z:e>), a pure HR lowering drug, reduces the myocardial oxygen demand at exercise, contributes to the restoration of oxygen balance and therefore benefit in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>No relevant negative effects are evidenced on cardiac conduction, contractility, relaxation, repolarization or blood pressure (BP) </plain></SENT>
<SENT sid="9" pm="."><plain>Beneficial effects of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IVA</z:e> have been demonstrated in CSAP and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>, with optimal tolerability profile due to selective interaction with If  channel of sino atrial node cells </plain></SENT>
<SENT sid="10" pm="."><plain>More recently, the indication of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IVA</z:e> has been extended for use in association with β-blockers in patients with CAD </plain></SENT>
<SENT sid="11" pm="."><plain>The aim of this review is point out the attention of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IVA</z:e> in treatment of <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> </plain></SENT>
</text></document>